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Abstract
Oral cancer is one of the commonest cancers among
males in India. This study was carried out to evaluate
the demographics, risk profile, clinicopathologic fea-
tures, and treatment outcome in young patients with
squamous cell carcinoma (SCC) of the tongue.
Patients under the age of 35 years with SCC of the
tongue presenting between 1982 and 1996 were
identified using institutions centralized electronic data-
base. Demographic, clinical, and pathologic character-
istics were abstracted from the case records. Survival
was calculated by Kaplan-Meier method. One hundred
and fifteen patients with histologically confirmed SCC
of the tongue were analyzed. The mean age at
presentation was 30.5 years with a 1.7:1 male to
female ratio. Prior exposure to tobacco and alcohol
was noted in 58 (50.5%) patients. At presentation, 70
(60.9%) were in stages III and IV, and 59 (51.3%)
patients had regional lymph node involvement. The
overall disease-free survival (DFS) at 3 and 5 years
were 63% and 54.9%, respectively. A statistically
significant difference in DFS was seen between
patients with N0 and N1 disease compared to N2 or
N3 disease. Various other factors like age, sex, habits,
and stage of the disease were found to have no
significant effect on DFS. Results of the present study
suggest that contrary to the belief, the survival among
young patients is almost similar to that in older
patients. Neoplasia (2001) 3, 273–277.
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Introduction
The tongue is the most common site for an oral cavity
malignancy. Tongue cancer represented 6.3% of all male
cancers and 3.7% of all female cancer cases in the Regional
Cancer Centre (RCC), Trivandrum, South India [1 ] . This
constituted about 36.5% of all oral malignancies. Peak
incidence is seen in the sixth decade for men and in the
seventh decade for women. In India, the high prevalence of
this cancer is attributed to the widespread habit of tobacco
chewing, smoking, and alcoholism.
Squamous cell carcinoma (SCC) of the oral tongue is
rare in young adults. Our understanding of its etiology,
natural history, and optimal therapeutic management is
limited due to the rarity of this tumor in young patients. Even
though tobacco and alcohol abuse is said to be the main
etiological factor, it is reported only for a small percentage of
patients in some series [2 ] . The lack of significant habits in
young patients have prompted many to postulate other
factors like immune deficiency [3,4] , genetic factors [5 ] ,
and dietary factors [6 ] in the etiology of these cancer.
Viruses like herpes simplex virus and human papilloma virus
[7 ] have also been reported as contributing factors. In the
few reported series on tongue cancer in young patients, the
general trend noted was the aggressive course and poor
prognosis [8 ] . We carried out this study to define the
demographics, risk profile, clinicopathologic features, and
treatment outcome among young adults with carcinoma of
the oral tongue.
Patients and Methods
A retrospective analysis of the patients under the age of 35
years with SCC of the tongue presented at RCC, Trivan-
drum between 1982 and 1996 was carried out. Data
extraction was carried from the electronic database of
RCC by the ICD codes for site and age <35. Variables
analyzed for each patient included age, sex, history of
tobacco and alcohol abuse, history of any cancer in first -
degree family members, and the presence of premalignant
lesions. The patients were staged according to the American
Joint Committee on Cancer (AJCC) staging system [9] .
Primary treatment given at our institution or elsewhere and
type of surgery and radiotherapy were extracted from case
records. Local, regional, and distant failures and second
primaries were taken as endpoints. All variables were
entered in a database for analysis. The Kaplan-Meier
method was used to calculate the overall and disease- free
survival (DFS) and log rank test was used for comparing
survival curves.
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Results
A total of 115 patients under the age of 35 years with SCC of
the tongue in the 15-year period from 1982 to 1996 were
analyzed. The mean age at presentation was 30.5 years
( range 18 to 35, SD 4.1) . There were 74 (64.3%) men and
41 (35.7%) women with a male to female ratio of 1.7:1
(Table 1) .
Family history of cancer was present in 14 (12.2%)
patients, whereas family history of oral cancer was
present only in 3 (2.6%) patients. Precancerous lesions
in the form of leukoplakia, submucous fibrosis, lichen
planus, and erythroplakia were present in 13 (11.3%)
patients. About half of the patients, 58 (50.5%), were
habituated to either tobacco or alcohol. Among them,
tobacco smoking outnumbered other risk factors, 49
(42.6%). Considering the habit distribution by age, more
habitue´s were found in the 31- to 35-year age group,
i.e., 44 (75.9%) compared to 14 (24.1%) patients <30
years of age.
About 55 (47.8%) of the tumors were well differ-
entiated, 41 (35.7%) were moderately differentiated, and
1 (0.9%) was poorly differentiated. Differentiation was not
known in 18 (15.6%) cases. At the time of presentation,
majority of the patients had T2 lesions (46; 40%) followed
by T1 in 24 (20.9%), T3 in 23 (20%), and T4 in 22 (19%).
Regional lymph node involvement was present in 59
(51.3%) patients. Considering the composite stage of the
disease, 45 (39%) patients were in early stages I and II,
whereas 70 (60.9%) were in advanced stages III and IV
(Table 2) . Taking stage of the disease by age, advanced
stage lesions (stages III and IV) were significantly more,
i.e., 39/70 (55.7%) in patients below 30 years compared
to 31 (44.3%) in those above 30 years of age. There were
significantly more node positive cases in patients below 30
years 33/59 (55.9%) compared to 26 (44%) in patients of
the 31 to 35 years age group. Among the node positive
cases, 35 (59.3%) patients were in N1 stage, 13 (22%)
were in N2, and 11 (18.6%) were in N3 stage. Considering
the nodal stage by age, N3 stage patients were signifi-
cantly higher in <30 years age group, 8/11 (72.7%),
compared to 3 (27.3%) in 31 to 35 years age group
(Table 2) .
Majority of the patients with early disease, 33/45
(73.3%), were treated by radiotherapy as the primary
modality, either alone (19/33) or followed by either
surgery (4/33) or chemotherapy (10/33) . Surgery as
the primary modality was employed in 25/70 (35.7%)
patients in stages III and IV either alone (6/25) or
followed by RT (19/25) . Chemoradiation was given to
15 (21.4%) patients, and palliative treatment alone was
given to 4 (5.7%) patients of advanced-stage disease.
Thirteen (11.3%) patients did not receive any treatment
because of either very advanced disease or the refusal for
treatment by the patients (Table 3) . The follow-up period
ranged from 1 to 202 months with a median follow-up time
of 19 months.
During follow-up, 32 (27.8%) patients developed
recurrence. Among these 13/32 (40.6%) had recurrence
Table 2. Stages at Presentation by Age among Patients with SCC of the








1 8 (6.9 ) 16 ( 13.9 )
2 19 (16.5 ) 27 ( 23.5 )
3 13 (11.3 ) 10 ( 8.7 )
4 12 (10.4 ) 10 ( 8.7 ) 3.4 ( 0.3 )
N stage
0 20 (17.4 ) 36 ( 31.3 )
1 19 (16.5 ) 16 ( 13.9 )
2 6 ( 5.2 ) 7 ( 6.1 )
3 8 ( 6.9 ) 3 ( 2.6 ) 7 (0.07 )
Composite stage
I 4 ( 3.5 ) 14 ( 12.2 )
II 9 ( 7.8 ) 18 ( 17.2 )
III 20 (17.4 ) 19 ( 16.5 )
IV 19 (16.5 ) 12 ( 10.4 ) 9.1 ( 0.05 )
Figures in parenthesis denote percentage unless specified.
Table 1. Age Distribution of the Young Patients with SCC of the Tongue
(n=115 ) .
Age Number (%)
<20 2 (1.8 )
21–25 14 (12.1 )
26–30 36 (31.4 )
31–35 63 (54.7 )
Table 3. Treatment Methods Adopted in Different Stages of Disease.











Radiotherapy alone 9 10 6 8 33 (29.5)
Surgery alone 0 2 4 2 8 (6.95)
R+S 3 1 5 0 9 (8)
S+R 2 2 9 10 23 (20.5)
R+C 2 8 10 5 25 (21.7)
Palliative treatment 0 0 1 3 4 (3.6)
No treatment 2 4 4 3 13 (11.3)
R, radiotherapy; S, surgery; C, chemotherapy.
Table 4. Status at Last Follow -Up.
Status Number (% ) , n=115
Dead 13 (11.3 )
Alive with disease 42 (36.5 )
Alive NED 47 (40.9 )
Loss of follow -up 13 (11.3 )
NED, no evidence of disease.
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at the primary site, 5 (15.6%) had nodal recurrence, 11
(34.4%) developed loco-regional recurrence, 1 (3.1%)
had second primary, whereas 2 (6.3%) developed distant
metastasis. For the recurrent lesions, surgery was
employed for salvage in 14 patients, radiation in 4 patients,
a combination of surgery and radiotherapy was given to
another 4 patients, and palliative treatment alone was
given to 10 patients. At the last follow-up, 13 (10.4%)
patients were dead, 47 (40.9%) were alive without any
evidence of disease and 42 (36.5) were alive with disease
(Table 4) .
The overall survival (OS) in this study group at 3 and 5
years was 91% and 87%, respectively. The overall DFS at
3 and 5 years was 63% and 54.9%, respectively (Figure
1 ) . The DFS in patients <30 years was 65% and 57.8% at
3 and 5 years compared to 61.8% and 53.6% in patients
>30 years. This difference was not statistically significant
(Figure 2 ) . Males were found to have an apparently better
DFS compared to females (61% and 52.2%, respectively,
at 5 years) ; however, the difference was not statistically
significant. Patients with early stage diseases (stages I and
II ) were found to have better DFS compared to advanced
stage lesions (stages III and IV) . The 3-year DFS was
79.9%, 77.7%, 60.5%,. and 37% for stages I, II, III, and IV,
respectively; this difference was also not statistically
significant. DFS in patients with N0 neck or with early
nodal disease N1 at 3 years were 72% and 58.7%,
respectively. Patients with advanced nodal disease (N2
Figure 1. Disease - free survival among the young Indian adults with tongue cancer.
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    >30 - censored
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Figure 2. Disease - free survival among patients with tongue cancer below the age of 30 years and those between 30 and 35 years of age.
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and N3) had a statistically significant difference in DFS at 3
years (28.5%) compared to the former group (P=.05)
(Table 5; Figure 3 ).
Discussion
This work presents one of the largest series of young
patients with SCC of the tongue. These constituted about
0.9% of all cases of oral cancer seen at RCC, Trivandrum,
India, during the same period. Only 12% patients had a
family history of cancer. Majority of the patients were males
and there was a steep increase in the frequency of cases as
the age advanced, supporting the etiological effect of habit.
In about 58 (50.5%) patients, disease could be attributed to
tobacco and/or alcohol exposure. Among them a substan-
tial number (49; 42.6%) were addicted to smoking. Out of
52, 38 (73%) patients under the age of 30 years had no
habits compared to 19/63 (30%) patients of the 31- to 35-
year age group. In an earlier review of 197 consecutive
patients treated for oral tongue cancer in Kerala, 82% of
patients under the age of 30 years did not had habits as
compared with 10% of patients older than 30 years of age
[2] . Another report comparing tongue cancer in young and
older patients in India concluded that in younger patients,
SCC of the tongue was associated with fewer etiological
factors, and in older patients, it was always seen in
association with smoking, alcohol or chewing [10] . How-
ever, this being a retrospective study, it is difficult to
comment on the exact relationship and level of exposures
among our patients.
Cancer of the tongue constituted about 43.6% of all
cases of oral cancer below the age of 35 years seen during
the same period. This is in contrast to the published reports
where tongue cancers constituted 75% to 80% of all
intraoral subsites in young patients [11] . In a review of all
oral cancer cases presented at our institution, tongue
cancer constituted 23.97% of all oral malignancies, cancer
of buccal mucosa was 49.9%, which outnumbered the
former [12] .
We have included patients only up to 35 years in the
present study, while Sarkaria and Harari [8] included
patients who were 39 years or younger. Comparative stage
distributions at presentation between these two series were:
stage I, 16% and 37%; stage II, 25% and 27%; stage III, 34%
Table 5. Disease -Free Survival (DFS ) by Various Factors.





Overall DFS 63 54.9
Sex
Male 65 61
Female 67 52.2 0.9
Age
<30 yr 65 57.8
31–35 yr 61 53.6 0.8
Habits
Present 59 51









IV 37 37 0.3
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    N2, N3-censored 
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     N0














Figure 3. Disease - free survival among young patients with tongue cancer by nodal status.
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and 20%; and stage IV, 27% and 16% in present and
published series, respectively [8 ] . In a review of 124 patients
they reported a loco- regional failure in 57% and cancer -
specific mortality in 47% of patients [8 ] . Son and Kapp [11]
identified 27 patients below the age of 40 years with SCC of
the oral cavity and oropharynx and reported failure rate to be
91%, which was higher than other reported series. However,
Pitman et al. [13] , in their report of 28 patients with cancer of
the tongue below the age of 40 years reported similar
outcomes of treatment for SCC of the oral tongue in young
patients and those older than 40 with similar extent of
disease. Survival among young patients has not been
reported from our center; however, irrespective of age, the
3-year survival with radium implant in tongue cancer was
71%, 55%, and 50%, respectively, in T1, T2, and T3 disease
[14] . Similarly, after radical radiotherapy the 3-year DFS
was 36%; it was 71% in stage I, 51% in stage II, 21% in stage
III, and 19% in stage IV disease [15] . The overall DFS at 3
years as well as stagewise DFS was significantly higher in
the present study, probably due to the use of multimodality
treatment in nearly 50% patients. The results for multi-
modality treatment from our center have not been reported.
Similar to the present study, the 5-year DFS reported by
Sarkaria and Harari [8] was 53%, while Friedlander et al.
[16] reported slightly higher rate (62%). We found no
statistically significant differences in survival between males
and females, between patients <30 years and the 31- to 35-
year age group, between habitue´s and nonhabitue´s, and
early or advanced disease. The only statistically significant
difference in DFS was noted between patients with N0 or
early nodal disease (N1) compared to those with advanced
nodal disease (N2, N3) (P=.05) .
Our data suggest that the survival among young patients
is almost similar to the older counterparts. As the results are
good in early stages of the disease, the best way to improve
the results seems to be clinical downstaging by community-
oriented early-detection programs and by increased public
awareness of oral cancer.
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